Business Outline
Basic Information
Company Name | Mitsubishi Tanabe Pharma Corporation |
---|---|
Capital Stock | 50 billion yen |
Representative Directors | TSUJIMURA Akihiro, UENO Hiroaki |
Headquarters | 3-2-10, Dosho-machi, Chuo-ku, Osaka 541-8505, Japan TEL: 81-6-6205-5085 |
Number of Employees | 6,370 (Consolidated) 3,107 (Non-consolidated)(As of March 31, 2023) |
Incorporated | December 13, 1933 |
Date of Merger | October 1, 2007 |
Business Activities
Pharmaceuticals
Manufacture and sale of pharmaceuticals, centered on ethical drugs
Major Ethical Drugs
Central nervous system | Dysval, Uplizna, Radicut | |
---|---|---|
Immuno-inflammation | Stelera, Simponi | |
Others | Diabetes and kidney | Tenelia, Canaglu, Canalia, Vafseo |
Allergy | Rupafin | |
Vaccines | Influenza vaccine, Tetrabik, Mearubik,Varicella vaccine, JEBIK V |
Major OTC Drugs
Agent for treatment of skin conditions | Flucort f, Cort f series |
---|---|
Digestive medicine | Tanabe ichoyaku〈choritsu〉, Tanabe ichoyaku urso, Cerekinon S |
Nutrient and tonic drink | Aspara drink α |
Allergic rhinitis medication | Talion AR |